Our investments.

RocketBio holds board seats and helps with business development, working alongside the teams as they build lasting relationships with their customers.

Our investments include companies developing human tissue models and microfluidic platforms for preclinical research. We work alongside their teams on commercial development, customer relationships and long-term growth.

01

VoxCell BioInnovation logo

Victoria, British Columbia

What they do

VoxCell develops vascularized, 3D-bioprinted human tissue models for preclinical research. Its models incorporate channels lined with endothelial cells, allowing researchers to investigate how compounds interact with tissue and its vascular features. Initial applications include breast and lung cancer research.

RocketBio holds a board seat and supports business development.

Selected collaborations

  • adMare BioInnovations

    Novel therapeutic. Commenced 2026.

  • BC Cancer

    Radiation, with the University of Victoria. Commenced 2025.

  • AbCellera

    Commenced 2025.

Explore the technology

voxcell.com

02

NETRI logo

Lyon, France

What they do

NETRI develops microfluidic platforms for studying human neuronal networks and their responses to compounds. Applications include pain research, chemotherapy-induced peripheral neuropathy, neurotoxicity and neurodegenerative disease.

RocketBio holds a board seat and supports business development.

Collaborations and programmes

NETRI is working with several pharmaceutical companies to evaluate its chemotherapy-induced neuropathic pain model. Public partners and programs are listed below.

  • Anses

    Pesticide neurotoxicity

  • Axion BioSystems

    Compartmentalized models with MEA electrophysiology. Collaboration since 2022; NeuroFluidics MEA launched in 2023.

  • Dassault Systèmes

    3DEXPERIENCE Lab

Explore the technology

netri.com

If you are considering a transition

Considering the next chapter for your business?

We welcome conversations with owners of established scientific tools and technology businesses who are considering a long-term partner.

Talk to us about a transition